Susan Y. Smith

发表

Intermittent Ibandronate Preserves Bone Quality and Bone Strength in the Lumbar Spine After 16 Months of Treatment in the Ovariectomized Cynomolgus Monkey

R. Müller, M. Hannan, Susan Y. Smith, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.

B. Komm, Susan Y. Smith, R. Samadfam, 2011, Bone.

Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.

Ian Pyrah, P. Kostenuik, Susan Y. Smith, 2011, Bone.

Biochemical Markers of Bone Turnover

Susan Y. Smith, R. Samadfam, 2017 .

Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys

Susan Y. Smith, S. Boyd, I. Pyrah, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Toxicology

Susan Y. Smith, R. Samadfam, A. Varela, 2017, Molecular and Integrative Toxicology.

Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys

P. Kostenuik, Susan Y. Smith, J. Jolette, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys

L. Duong, Susan Y. Smith, G. Wesolowski, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.

P. Kostenuik, Susan Y. Smith, I. Pyrah, 2011, Bone.

Does Activin Receptor Blockade by Bimagrumab (BYM338) Pose Detrimental Effects on Bone Healing in a Rat Fibula Osteotomy Model?

J. Goldhahn, L. Tankó, Susan Y. Smith, 2016, Calcified Tissue International.

Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone.

D. Burr, Susan Y. Smith, M. Grynpas, 2015, Bone.

Prevention of Bone Loss in Ovariectomized Rats by Combined Treatment With Risedronate and 1α,25‐Dihydroxyvitamin D3

Susan Y. Smith, R. Erben, L. Mosekilde, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Nonhuman Primate Models of Osteoporosis

Susan Y. Smith, J. Jolette, A. Varela, 2011 .

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

D. Lacey, Susan Y. Smith, M. Stolina, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Treatment of Skeletally Mature Ovariectomized Rhesus Monkeys With PTH(1‐84) for 16 Months Increases Bone Formation and Density and Improves Trabecular Architecture and Biomechanical Properties at the Lumbar Spine

R. Recker, Susan Y. Smith, C. Turner, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats

Susan Y. Smith, R. Samadfam, S. Takeda, 2014, Calcified Tissue International.

Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats

R. Guldberg, Susan Y. Smith, F. Bauss, 2015, Journal of Bone and Mineral Metabolism.

The Effect of Rosiglitazone on Bone Mass and Fragility Is Reversible and Can Be Attenuated With Alendronate

R. Guldberg, Susan Y. Smith, P. Mansell, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.

Susan Y. Smith, L. Chouinard, N. Doyle, 2013, Bone.

One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption

Susan Y. Smith, G. Hattersley, E. Lesage, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)

Susan Y. Smith, G. Hattersley, G. Long, 2017, Regulatory toxicology and pharmacology : RTP.

Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats

Susan Y. Smith, J. Jolette, J. Hardisty, 2006, Toxicologic pathology.

Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model

L. Duong, Susan Y. Smith, D. Kimmel, 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.

Susan Y. Smith, F. Bauss, M. Wright, 2012, The Journal of endocrinology.

Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.

Susan Y. Smith, F. Bauss, M. Wright, 2012, The Journal of endocrinology.

Combination treatment with pioglitazone and fenofibrate attenuates

Susan Y. Smith, F. Bauss, M. Wright, 2011 .

Increases in adipose and total body weight, but not in lean body mass, associated with subcutaneous administration of Sonic hedgehog‐Ig fusion protein to mice

Susan Y. Smith, A. Galdes, Pauline L. Martin, 2002 .

ALX-0141, an anti-rank-L targeting nanobody®, increases bone mass in cynomolgus monkeys

Susan Y. Smith, M. V. Roy, J. Holz, 2012 .

Combined activation of PPAR-gamma and PPAR-alpha reduces the negative effects of PPAR-gamma agonism on bone and may attenuate PPAR-gamma-mediated loss of bone strength

Susan Y. Smith, F. Bauss, M. Wright, 2012 .

A Toxicity Profile of Osteoprotegerin in the Cynomolgus Monkey

Steven W. Martin, Susan Y. Smith, R. Gregson, 2003, International journal of toxicology.

Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis.

L. Tankó, Susan Y. Smith, P. Qvist, 2006, Arthritis and rheumatism.

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.

Susan Y. Smith, P. Mann, I. Pyrah, 2016, Regulatory toxicology and pharmacology : RTP.

Instilled or Injected Purified Natural Capsaicin Has No Adverse Effects on Rat Hindlimb Sensory-Motor Behavior or Osteotomy Repair

E. Longstaff, Susan Y. Smith, D. Patrick, 2009, Anesthesia and analgesia.

Assessment of a nonsteroidal aromatase inhibitor, letrozole, in juvenile rats.

Susan Y. Smith, M. Decristofaro, Marilyn J. Schneider, 2013, Birth defects research. Part B, Developmental and reproductive toxicology.

Dog Juvenile Toxicity

Susan Y. Smith, A. Viau, K. Robinson, 2012 .

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

Daniel J Lightwood, D. Lacey, Susan Y. Smith, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey

B. Komm, Susan Y. Smith, J. Jolette, 2015, Journal of Bone and Mineral Metabolism.

Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats

Susan Y. Smith, R. Samadfam, S. Takeda, 2014, Calcified Tissue International.

Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs.

Susan Y. Smith, D. Gargallo‐Viola, I. Zsolt, 2018, Future microbiology.

One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.

P. Kostenuik, R. Guldberg, Susan Y. Smith, 2017, Bone.

Cathepsin K inhibitors prevent bone loss in estrogen‐deficient rabbits

L. Duong, Susan Y. Smith, D. Kimmel, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Introduction and Considerations in Bone Toxicology

Susan Y. Smith, Nancy Doyle, Melanie Felx, 2017 .

Abaloparatide (BA058), a novel human PTHrP analog, restores bone mass and strength in the aged osteopenic ovariectomized cynomolgus monkey

R. Guldberg, Susan Y. Smith, G. Hattersley, 2014 .

Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.

R. Recker, Susan Y. Smith, M. Miller, 2009, Bone.

Does Activin Receptor Blockade by Bimagrumab (BYM338) Pose Detrimental Effects on Bone Healing in a Rat Fibula Osteotomy Model?

J. Goldhahn, L. Tankó, Susan Y. Smith, 2016, Calcified Tissue International.

Evaluation of Cartilage and Bone Degradation in a Murine Collagen Antibody‐induced Arthritis Model

M. Karsdal, Susan Y. Smith, P. Qvist, 2008, Scandinavian journal of immunology.

Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.

R. Müller, R. Recker, M. Hannan, 2003, Bone.

Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.

R. Recker, Susan Y. Smith, J. Fox, 2005, Journal of musculoskeletal & neuronal interactions.

Effects of Treatment with Parathyroid Hormone 1–84 on Quantity and Biomechanical Properties of Thoracic Vertebral Trabecular Bone in Ovariectomized Rhesus Monkeys

R. Guldberg, Susan Y. Smith, C. Turner, 2008, Calcified Tissue International.

Comparison of osteosarcoma incidence between abaloparatide (BA058) and PTH (1--34) in long term rat studies

Susan Y. Smith, G. Hattersley, A. Varela, 2014 .